First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

Aim. To assess the efficacy and toxicity of intensive 6 courses EACOPP-14 treatment with or without radiotherapy (RT) for advanced stages of Hodgkin’s lymphoma (HL). Materials & Methods. From November 2009 to February 2015, 95 patients with advanced stages of HL (IIX–IIE, III–IV) aged between...

Full description

Bibliographic Details
Main Authors: EA Demina, AA Leont’eva, GS Tumyan, YuE Ryabukhina, OP Trofimova, NV Volkova, YuI Pryamikova, VM Sotnikov, VB Larionova, EG Medvedovskaya, EV Paramonova, LV Manzyuk, NA Probatova, NV Kokosadze, EA Osmanov
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2017-10-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
Hodgkin’s lymphoma
advanced stages
intensive first-line chemotherapy
Online Access:http://bloodjournal.ru/wp-content/uploads/2017/10/3_1.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2017/10/3_1.pdf

Similar Items